Skip to main content
SpringerLink
Log in
Book cover

Travel Medicine pp 169–181Cite as

General Use Immunizations for Travelers

  • Chapter

  • 30 Accesses

Summary

Immunizations for travelers can be divided into two categories: those required solely by various country regulations (cholera and yellow fever vaccines), and those recommended specifically for the health and well-being of the traveler. Some immunizations in the second category are recommended only under special circumstances (e.g., typhoid, meningococcal, Japanese encephalitis, and yellow fever vaccines). Others are recommended on a more routine basis since they are included in the routine immunization schedule of a particular country. The latter are “general-use” immunizations and include diphtheria and tetanus toxoids and pertussis vaccine (DTP); pediatric and adult diphtheria and tetanus toxoids (DT and Td, respectively); and measles and polio vaccines. Rubella, BCG, and mumps vaccines may also be included in this classification. In contrast with many other travel-related immunizations, recommendations for these “general-use” immunizations are relatively straightforward. They are usually indicated for any traveler who does not have documented immunity, provided there are no contraindications to their administration. The issues most frequently raised regarding administration of the “general-use” immunizations include (1) the criteria for immunity, (2) the simultaneous administration of these and other immunizations, (3) the minimum interval required between doses when departure necessitates an accelerated immunization schedule, and (4) the minimum age at which they can be administered to infants. As the number of international travelers increases, and as countries strive both to safeguard the health of travelers and to limit the importation and spread of vaccine-preventable diseases, attention to these “general-use” immunizations becomes increasingly important.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Mann JM (1983) Emporiatric policy and practice: protecting the health of Americans abroad. JAMA 249:3323–3325

    Article  PubMed  CAS  Google Scholar 

  2. Rust RE, Peate WF, Cordes DH (1986) Comprehensive care of travelers. J Fam Pract 23:572–579

    Google Scholar 

  3. Steffan R, Rickenbach M, Wilhelm U, Helminger A, Schar M (1987) Health problems after travel to developing countries. J Infect Dis 156:84–91

    Article  Google Scholar 

  4. CDC (1987) Health information for international travel 1988. CDC, Washington DHHS publ no (CDC) 88–8280

    Google Scholar 

  5. CDC (1989) Recommendations of the Immunization Practices Advisory Committee (ACIP). General recommendations on immunizations. MMWR 38:205–214, 219–227

    Google Scholar 

  6. CDC (1986) Recommendations of the Immunization Practices Advisory Committee (ACIP). New recommended schedule for active immunization of normal infants and children. MMWR 35:577–579

    Google Scholar 

  7. Deforest A, Long SS, Lischner HW et al. (1988) Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. Pediatrics 81:237–246

    PubMed  CAS  Google Scholar 

  8. Eskola J, Peltola H, Takala AK et al. (1987) Efficacy of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infancy. N Engl J Med 317:717–722

    Article  PubMed  CAS  Google Scholar 

  9. CDC (1985) Recommendations of the Immunization Practices Advisory Committee (ACIP). Diphtheria, tetanus, and pertussis: guidelines for vaccine prophylaxis and other preventive measures. MMWR 34:405–414, 419–426

    Google Scholar 

  10. CDC (1987) Recommendations of the Immunization Practices Advisory Committee (ACIP). Pertussis immunization; family history of convulsions and use of antipyretics – Supplementary ACIP statement. MMWR 36:281–282

    Google Scholar 

  11. Halsey N, Galazka A (1985) The efficacy of DTP and oral poliomyelitis immunization schedules initiated from birth to 12 weeks of age. Bull WHO 63:1151–1169

    PubMed  CAS  Google Scholar 

  12. Orenstein WA, Weisfeld JS, Halsey NA (1983) Diphtheria and tetanus toxoids and pertussis vaccine, combined. In: Halsey NA, de Quadros CA (eds) Recent advances in immunization: a bibliographic review. Pan American Health Organization, pp 30–51 (Scientific publ no 451)

    Google Scholar 

  13. Barkin RM, Samuleson JS, Gotlin LP (1984) DTP reactions and serologic response with a reduced dose schedule. J Pediatr 105:189–194

    Article  PubMed  CAS  Google Scholar 

  14. Ross E, Miller D (1986) Risk and pertussis vaccine (Letter). Arch Dis Child 61:98–99

    Article  PubMed  CAS  Google Scholar 

  15. CDC (1982) Recommendations of the Immunization Practices Advisory Committee (ACIP). Poliomyelitis prevention. MMWR 31:22–26, 31–34

    Google Scholar 

  16. CDC (1987) Recommendations of the Immunization Practices Advisory Committee (ACIP). Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine – Supplementary statement. MMWR 36:795–798

    Google Scholar 

  17. Bernier RH (1986) Improved inactivated poliovirus vaccine: an update. Pediatr Infect Dis 5:289–292

    Article  PubMed  CAS  Google Scholar 

  18. Expanded Program on Immunization (1985) Global advisory group. Weekly Epidemiol Rec 60:13–16

    Google Scholar 

  19. Nkwane BM, Wassilak SGF, Orenstein WA, Bart KJ, Schoenberger LB, Hinman AR, Kew O (1987) Vaccine-associated paralytic poliomyelitis. United States: 1974 through 1984. JAMA 257:1335–1340

    Article  Google Scholar 

  20. Miller DL (1964) Frequency of complications of measles, 1963. Report on a national inquiry by the Public Health Laboratory Service in collaboration with the Society of Medical Officers of Health. Br Med J 2:75–78

    Article  PubMed  CAS  Google Scholar 

  21. CDC (1987) Recommendations of the Immunization Practices Advisory Committee (ACIP). Measles prevention. MMWR 36:409–418, 423–425

    Google Scholar 

  22. Orenstein WA, Markowitz L, Preblud SR, Hinman AR, Tomasi A, Bart KJ (1986) Appropriate age for measles vaccination in the United States. Dev Biol Stand 65:13–21

    PubMed  CAS  Google Scholar 

  23. CDC (1986) Recommendations of the Immunization Practices Advisory Committee (ACIP). Immunization of children infected with human T-lymphotrophic virus type III/lymphadenopathy associated virus. MMWR 35:595–598, 603–606

    Google Scholar 

  24. CDC (1988) Recommendations of the Immunization Practices Advisory Committee (ACIP). Immunization of children infected with human immunodeficiency virus - Supplementary ACIP statement. MMWR 37:181–183

    Google Scholar 

  25. CDC (1988) Measles in HIV-infected children, United States. MMWR 37:183–186

    Google Scholar 

  26. Von Reyn CF, Clements CJ, Mann JM (1987) Human immunodeficiency virus infection and routine childhood immunisation. Lancet 11:669–672

    Article  Google Scholar 

  27. Herman J J, Radin R, Schneiderman R (1983) Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein. J Pediatr 102:196–199

    Article  PubMed  CAS  Google Scholar 

  28. Miller E, Cradock-Watson JE, Pollock TM (1982) Consequences of confirmed maternal rubella at successive stages of pregnancy. Lancet 11:781–784

    Article  Google Scholar 

  29. CDC (1984) Recommendations of the Immunization Practices Advisory Committee (ACIP). Rubella prevention. MMWR 33:301–310, 315–318

    Google Scholar 

  30. Preblud SR (1985) Some current issues relating to rubella vaccine. JAMA 254:253–256

    Article  PubMed  CAS  Google Scholar 

  31. Preblud SR, Serdula MK, Frank JA Jr, Brandling-Bennett AD, Hinman AR (1980) Rubella vaccination in the United States: a ten-year review. Epidemiol Rev 2:171–194

    PubMed  CAS  Google Scholar 

  32. Tingle AJ, Chantler JK, Pot KH, Paty DW, Ford DK (1985) Postpartum rubella immunization: association with development of prolonged arthritis, neurological sequelae, and chronic rubella viremia. J Infect Dis 254:253–256

    Google Scholar 

  33. Preblud SR, Orenstein WA, Lopez CL, Herrmann KL, Hinman AR (1986) Postpartum rubella immunization (Letter). J Infect Dis 154:367–368

    Article  PubMed  CAS  Google Scholar 

  34. Tingle AJ (1986) Postpartum rubella immunization (Letter). J Infect Dis 154:368–369

    Article  Google Scholar 

  35. CDC (1989) Rubella vaccination during pregnancy - United States, 1971–1988. MMWR 38:289–293

    Google Scholar 

  36. CDC (1982) Recommendations of the Immunization Practices Advisory Committee (ACIP). Mumps vaccine. MMWR 31:617–620, 625

    Google Scholar 

  37. CDC (1985) Recommendations of the Immunization Practices Advisory Committee (ACIP). Polysaccharide vaccine for prevention of Haemophilus influenzae type b disease. MMWR 34:201–205

    Google Scholar 

  38. CDC (1988) Recommendations of the Immunization Practices Advisory Committee (ACIP). Update: prevention of Haemophilus influenzae type b disease. MMWR 37:13–16

    Google Scholar 

  39. Markowitz LE, Tomasi A, Hawkins CE, Preblud SR, Orenstein WA, Hinman AR (1987) International measles importations: United States, 1980–1985. Int J Epidemiol 17:101–105

    Google Scholar 

  40. Hinman AR (1985) Costs of not eradicating measles. Am J Public Health 75:713–714

    Article  PubMed  CAS  Google Scholar 

  41. Hinman AR, Foege WH, de Quadros CA, Patriarca PA, Orenstein WA, Brink EW (1987) The case for global eradication of poliomyelitis. Bull WHO 65:835–840

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. R. Preblud
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. W. Brink
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. A. Orenstein
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Sozial- und Präventivmedizin der Universität Zürich, Sumatrastraße 30, CH-8006, Zürich, Switzerland

    Robert Steffen

  2. Malaria Branch, Centers for Disease Control, Atlanta, GA, 30333, USA

    Hans Lobel

  3. Chemin Roitelet 5, CH-1292, Chambèsy, Switzerland

    James Haworth

  4. London School of Hygiene and Tropical Medicine, Keppel Street, London, WCLE 7HT, England

    David J. Bradley MA, DM, FRCPath, FFCM, FRCP, FlBiol, Hon. FlPHE

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Preblud, S.R., Brink, E.W., Orenstein, W.A. (1989). General Use Immunizations for Travelers. In: Steffen, R., Lobel, H., Haworth, J., Bradley, D.J. (eds) Travel Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73772-5_32

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73772-5_32

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-73774-9

  • Online ISBN: 978-3-642-73772-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation